Changle Xin links OTC to drive new growth in pharmacies

——Linaxin Health Expo Theme Speech

On July 14th, 2022, the International Health Industry (Chongqing) Expo and the 7th Double Product Fair (hereinafter referred to as the Health Expo) were grandly opened at the Nanping International Convention and Exhibition Center in Chongqing.

More than 5000 authoritative scholars, senior industry experts, global cross-border celebrities, and pharmaceutical companies from all over the country attended the conference to share new ideas, technologies, and achievements in industry development.

As an invited exhibitor in the field of home health self inspection, Linaxin Biotechnology showcased its advanced domestic technology in early screening products, which have been favored by numerous chain pharmacies and third-party terminals, and have reached multiple cooperation intentions. On the evening of the 14th, Linaxin Biotechnology and many pharmaceutical industry experts held a discussion at the forum on "New Scenarios, New Needs, Stimulating Non Drug New Growth". Vice General Manager Zhu Wanjie gave a speech on the theme of "Changlixin Linking OTC to Drive New Growth in Pharmacies". Combining Changlixin's mature application in public hospitals and physical examination centers, he shared how to provide new growth momentum for OTC channels in the future, which received warm attention from the pharmaceutical industry and chains present.

At the meeting, Tan Shengwei, General Manager of Linaxin Biotechnology, held a strategic cooperation signing ceremony with Shuyu Pingmin, Anhui Guosheng, Xinjiang Baicaotang, Tangshan Tangren, Sichuan Zhenghexiang, Guangxi Yixin Pharmaceutical, Harbin Health, Big Health International Group, Shaanxi Lerongrong, Sichuan Gerui, Hubei Changbanpo, Shaanxi Yikang, Shanxi En'elai, Fujian Zhonglian, and Nantong Kangshun, laying the foundation for the future entry of home health self inspection products mainly based on Changlixin into major chain pharmacies.

Xu Yuping, the Chairman of the Supervisory Board of the China Medical Supplies Association, analyzed and looked forward to the prospects of POCT rapid diagnostic products in OTC pharmacies at the forum. He also affirmed the exploration of Linaxin Biotechnology in the field of home health self inspection, believing that home self inspection products will definitely become a strong growth point for OTC pharmacies in the future.

Linaxin Biotechnology showcased its technological strength and product prospects through this conference, and established deep cooperation with pharmaceutical companies from all walks of life across the country. In the future, it will also gather industry forces to jointly explore the development of home health self inspection industry, and contribute its own strength to the innovative and leapfrog development of the pharmaceutical health industry.